Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-prolyl aminopeptidase 3 (XPNPEP3) is a mitochondrial and cytosolic enzyme that removes the N-terminal amino acid from peptides where a proline resides in the penultimate position, and is critical for mitochondrial protein processing and stability. It functions as a metallopeptidase (M24B family), utilizing a metal cofactor for activity, and is essential for mitochondrial proteostasis. XPNPEP3 is also involved in ciliary function, and mutations in this gene cause nephronophthisis-like ciliopathy (a cystic kidney disease). Beyond its enzymatic role, one isoform (localized to mitochondria) acts as an adaptor in TNF-TNFR2 signaling, modulating cell death pathways independently of its enzymatic activity. Structural studies reveal distinct substrate specificity and a unique pocket accommodating proline in the P1’ position[1][2][3][4][5].
Inhibitors may act by binding to the active site and blocking catalytic removal of the N-terminal residue (as shown with apstatin in crystal structure analyses)[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-prolyl aminopeptidase 3 (XPNPEP3).